Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Cantó E[au]:

Search results

Items: 1 to 50 of 79

1.

Antimicrobial peptides, disease severity and exacerbations in bronchiectasis.

Sibila O, Perea L, Cantó E, Shoemark A, Cassidy D, Smith AH, Suarez-Cuartin G, Rodrigo-Troyano A, Keir HR, Oriano M, Ong S, Vidal S, Blasi F, Aliberti S, Chalmers JD.

Thorax. 2019 Jul 5. pii: thoraxjnl-2018-212895. doi: 10.1136/thoraxjnl-2018-212895. [Epub ahead of print]

PMID:
31278172
2.

A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation.

Shoemark A, Cant E, Carreto L, Smith A, Oriano M, Keir HR, Perea L, Canto E, Terranova L, Vidal S, Moffitt K, Aliberti S, Sibila O, Chalmers JD.

Eur Respir J. 2019 Jun 13;53(6). pii: 1900303. doi: 10.1183/13993003.00303-2019. Print 2019 Jun.

PMID:
31151955
3.

Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.

Didonna A, Cantó E, Shams H, Isobe N, Zhao C, Caillier SJ, Condello C, Yamate-Morgan H, Tiwari-Woodruff SK, Mofrad MRK, Hauser SL, Oksenberg JR.

J Autoimmun. 2019 Jul;101:56-69. doi: 10.1016/j.jaut.2019.04.003. Epub 2019 Apr 19.

PMID:
31010726
4.

Association of Platelet Binding to Lymphocytes with B Cell Abnormalities and Clinical Manifestations in Systemic Lupus Erythematosus.

Zamora C, Toniolo E, Diaz-Torné C, Cantó E, Magallares B, Ortiz MA, Perea L, Corominas H, Vidal S.

Mediators Inflamm. 2019 Mar 3;2019:2473164. doi: 10.1155/2019/2473164. eCollection 2019.

5.

Effects of a polysaccharide-based multi-ingredient supplement on salivary immunity in non-elite marathon runners.

Roca E, Cantó E, Nescolarde L, Perea L, Bayes-Genis A, Sibila O, Vidal S.

J Int Soc Sports Nutr. 2019 Mar 25;16(1):14. doi: 10.1186/s12970-019-0281-z.

6.

Salivary immunity and lower respiratory tract infections in non-elite marathon runners.

Cantó E, Roca E, Perea L, Rodrigo-Troyano A, Suarez-Cuartin G, Giner J, Feliu A, Soria JM, Nescolarde L, Vidal S, Sibila O.

PLoS One. 2018 Nov 21;13(11):e0206059. doi: 10.1371/journal.pone.0206059. eCollection 2018.

7.

Bacteria-related Events and the Immunological Response of Onset and Relapse Adult Crohn's Disease Patients.

Cantó E, Zamora C, Garcia-Planella E, Gordillo J, Ortiz MA, Perea L, Vidal S.

J Crohns Colitis. 2019 Jan 1;13(1):92-99. doi: 10.1093/ecco-jcc/jjy138.

PMID:
30247652
8.

Ascitic fluid regulates the local innate immune response of patients with cirrhosis.

Nieto JC, Perea L, Soriano G, Zamora C, Cantó E, Medina A, Poca M, Sanchez E, Roman E, Julià G, Navarro F, Gely C, Alvarado EA, Guarner C, Juarez C, Vidal S.

J Leukoc Biol. 2018 Oct;104(4):833-841. doi: 10.1002/JLB.3A0218-072R. Epub 2018 May 31.

PMID:
29851144
9.

Inverse Association Between Circulating Monocyte-Platelet Complexes and Inflammation in Ulcerative Colitis Patients.

Zamora C, Canto E, Nieto JC, Garcia-Planella E, Gordillo J, Ortiz MA, Suarez-Calvet X, Perea L, Julia G, Juarez C, Vidal S.

Inflamm Bowel Dis. 2018 Mar 19;24(4):818-828. doi: 10.1093/ibd/izx106.

PMID:
29529212
10.

Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients.

Canto E, Isobe N, Didonna A; MS-EPIC Study Group, Hauser SL, Oksenberg JR.

J Neuroinflammation. 2018 Mar 7;15(1):72. doi: 10.1186/s12974-018-1105-9.

11.

Multiple sclerosis genetics.

Canto E, Oksenberg JR.

Mult Scler. 2018 Jan;24(1):75-79. doi: 10.1177/1352458517737371. Review.

PMID:
29307290
12.

The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab.

Diaz-Torne C, Ortiz MDA, Moya P, Hernandez MV, Reina D, Castellvi I, De Agustin JJ, Fuente D, Corominas H, Sanmarti R, Zamora C, Cantó E, Vidal S.

Semin Arthritis Rheum. 2018 Jun;47(6):757-764. doi: 10.1016/j.semarthrit.2017.10.022. Epub 2017 Nov 20.

PMID:
29157669
13.

CSF-1 regulates the function of monocytes in Crohn's disease patients in remission.

Nieto JC, Zamora C, Cantó E, Garcia-Planella E, Gordillo J, Ortiz MA, Juárez C, Vidal S.

Sci Rep. 2017 Mar 7;7(1):92. doi: 10.1038/s41598-017-00145-4.

14.

Binding of Platelets to Lymphocytes: A Potential Anti-Inflammatory Therapy in Rheumatoid Arthritis.

Zamora C, Cantó E, Nieto JC, Bardina J, Diaz-Torné C, Moya P, Magallares B, Ortiz MA, Julià G, Juarez C, Llobet JM, Vidal S.

J Immunol. 2017 Apr 15;198(8):3099-3108. doi: 10.4049/jimmunol.1601708. Epub 2017 Mar 1.

15.

MRI phenotypes with high neurodegeneration are associated with peripheral blood B-cell changes.

Comabella M, Cantó E, Nurtdinov R, Río J, Villar LM, Picón C, Castilló J, Fissolo N, Aymerich X, Auger C, Rovira A, Montalban X.

Hum Mol Genet. 2016 Jan 15;25(2):308-16. doi: 10.1093/hmg/ddv473. Epub 2015 Nov 24.

PMID:
26604134
16.

Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple Sclerosis.

Borràs E, Cantó E, Choi M, Maria Villar L, Álvarez-Cermeño JC, Chiva C, Montalban X, Vitek O, Comabella M, Sabidó E.

Mol Cell Proteomics. 2016 Jan;15(1):318-28. doi: 10.1074/mcp.M115.053256. Epub 2015 Nov 9.

17.

Peripheral blood non-MAIT CD8+CD161hi cells are decreased in relapsing-remitting multiple sclerosis patients treated with interferon beta.

Negrotto L, Cantó E, Río J, Tintoré M, Montalban X, Comabella M.

J Neuroimmunol. 2015 Nov 15;288:98-101. doi: 10.1016/j.jneuroim.2015.09.007. Epub 2015 Sep 25.

PMID:
26531701
18.

PML risk stratification using anti-JCV antibody index and L-selectin.

Schwab N, Schneider-Hohendorf T, Pignolet B, Spadaro M, Görlich D, Meinl I, Windhagen S, Tackenberg B, Breuer J, Cantó E, Kümpfel T, Hohlfeld R, Siffrin V, Luessi F, Posevitz-Fejfár A, Montalban X, Meuth SG, Zipp F, Gold R, Du Pasquier RA, Kleinschnitz C, Jacobi A, Comabella M, Bertolotto A, Brassat D, Wiendl H.

Mult Scler. 2016 Jul;22(8):1048-60. doi: 10.1177/1352458515607651. Epub 2015 Oct 2.

PMID:
26432858
19.

Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis induction.

Cantó E, Espejo C, Costa C, Montalban X, Comabella M.

Clin Immunol. 2015 Oct;160(2):133-41. doi: 10.1016/j.clim.2015.06.004. Epub 2015 Jun 12.

PMID:
26079949
20.

IL-6 blockade reverses the abnormal STAT activation of peripheral blood leukocytes from rheumatoid arthritis patients.

Ortiz MA, Diaz-Torné C, Hernández MV, Reina D, de la Fuente D, Castellví I, Moya P, Ruiz JM, Corominas H, Zamora C, Cantó E, Sanmartí R, Juarez C, Vidal S.

Clin Immunol. 2015 Jun;158(2):174-82. doi: 10.1016/j.clim.2015.03.025. Epub 2015 Apr 3.

PMID:
25847223
21.

Reply to letter from DeVon et al. - Time to standardize and broaden the criteria of acute coronary syndrome symptom presentations in women.

Canto JG, Canto EA, Goldberg RJ.

Can J Cardiol. 2015 Mar;31(3):365.e1. doi: 10.1016/j.cjca.2014.10.017. Epub 2014 Oct 17. No abstract available.

PMID:
25746027
22.

Reductive dismantling and functionalization of carbon nanohorns.

Voiry D, Pagona G, Del Canto E, Ortolani L, Morandi V, Noé L, Monthioux M, Tagmatarchis N, Penicaud A.

Chem Commun (Camb). 2015 Mar 25;51(24):5017-9. doi: 10.1039/c4cc10389k.

PMID:
25703482
23.

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.

Cantó E, Tintoré M, Villar LM, Costa C, Nurtdinov R, Álvarez-Cermeño JC, Arrambide G, Reverter F, Deisenhammer F, Hegen H, Khademi M, Olsson T, Tumani H, Rodríguez-Martín E, Piehl F, Bartos A, Zimova D, Kotoucova J, Kuhle J, Kappos L, García-Merino JA, Sánchez AJ, Saiz A, Blanco Y, Hintzen R, Jafari N, Brassat D, Lauda F, Roesler R, Rejdak K, Papuc E, de Andrés C, Rauch S, Khalil M, Enzinger C, Galimberti D, Scarpini E, Teunissen C, Sánchez A, Rovira A, Montalban X, Comabella M.

Brain. 2015 Apr;138(Pt 4):918-31. doi: 10.1093/brain/awv017. Epub 2015 Feb 13.

PMID:
25688078
24.

Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.

Cantó E, Tintoré M, Villar LM, Borrás E, Alvarez-Cermeño JC, Chiva C, Sabidó E, Rovira A, Montalban X, Comabella M.

J Neuroinflammation. 2014 Nov 13;11:181. doi: 10.1186/s12974-014-0181-8.

25.

Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis.

Zamora-Atenza C, Diaz-Torne C, Geli C, Diaz-Lopez C, Ortiz MA, Moya P, Castellví I, Nieto JC, Cantó E, Casademont J, Juarez C, Llobet JM, Vidal S.

Arthritis Res Ther. 2014 Jul 18;16(4):R153. doi: 10.1186/ar4615.

26.

Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis.

Fissolo N, Cantó E, Vidal-Jordana A, Castilló J, Montalban X, Comabella M.

J Neuroimmunol. 2014 Jun 15;271(1-2):56-9. doi: 10.1016/j.jneuroim.2014.04.001. Epub 2014 Apr 16.

PMID:
24794503
27.

Interleukin-19 impairment in active Crohn's disease patients.

Cantó E, Garcia Planella E, Zamora-Atenza C, Nieto JC, Gordillo J, Ortiz MA, Metón I, Serrano E, Vegas E, García-Bosch O, Juárez C, Vidal S.

PLoS One. 2014 Apr 9;9(4):e93910. doi: 10.1371/journal.pone.0093910. eCollection 2014.

28.

Time to standardize and broaden the criteria of acute coronary syndrome symptom presentations in women.

Canto JG, Canto EA, Goldberg RJ.

Can J Cardiol. 2014 Jul;30(7):721-8. doi: 10.1016/j.cjca.2013.10.015. Epub 2013 Oct 25. Review.

PMID:
24530216
29.

Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis.

Díaz-Torné C, Ortiz de Juana MA, Geli C, Cantó E, Laiz A, Corominas H, Casademont J, de Llobet JM, Juárez C, Díaz-López C, Vidal S.

Immunology. 2014 Jul;142(3):354-62. doi: 10.1111/imm.12212.

30.

Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis.

Moreno M, Sáenz-Cuesta M, Castilló J, Cantó E, Negrotto L, Vidal-Jordana A, Montalban X, Comabella M.

J Neuroimmunol. 2013 Oct 15;263(1-2):152-4. doi: 10.1016/j.jneuroim.2013.07.013. Epub 2013 Jul 26.

PMID:
23932896
31.

Functional consequences of platelet binding to T lymphocytes in inflammation.

Zamora C, Cantó E, Nieto JC, Ortiz MA, Diaz-Torné C, Diaz-Lopez C, Llobet JM, Juarez C, Vidal S.

J Leukoc Biol. 2013 Sep;94(3):521-9. doi: 10.1189/jlb.0213074. Epub 2013 Jun 25.

PMID:
23801652
32.

Functional consequences of CD36 downregulation by TLR signals.

Zamora C, Cantó E, Nieto JC, Angels Ortiz M, Juarez C, Vidal S.

Cytokine. 2012 Oct;60(1):257-65. doi: 10.1016/j.cyto.2012.06.020. Epub 2012 Jul 12.

PMID:
22795952
33.

Photo-controlled release of zinc metal ions by spiropyran receptors anchored to single-walled carbon nanotubes.

Del Canto E, Natali M, Movia D, Giordani S.

Phys Chem Chem Phys. 2012 May 7;14(17):6034-43. doi: 10.1039/c2cp40275k. Epub 2012 Mar 23.

PMID:
22446851
34.

Selective loss of chemokine receptor expression on leukocytes after cell isolation.

Nieto JC, Cantó E, Zamora C, Ortiz MA, Juárez C, Vidal S.

PLoS One. 2012;7(3):e31297. doi: 10.1371/journal.pone.0031297. Epub 2012 Mar 5.

35.

Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.

Cantó E, Reverter F, Morcillo-Suárez C, Matesanz F, Fernández O, Izquierdo G, Vandenbroeck K, Rodríguez-Antigüedad A, Urcelay E, Arroyo R, Otaegui D, Olascoaga J, Saiz A, Navarro A, Sanchez A, Domínguez C, Caminero A, Horga A, Tintoré M, Montalban X, Comabella M.

Mult Scler. 2012 Jul;18(7):983-90. doi: 10.1177/1352458511433063. Epub 2011 Dec 19.

PMID:
22183936
36.

Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression.

Moga E, Cantó E, Vidal S, Juarez C, Sierra J, Briones J.

Exp Hematol. 2011 Nov;39(11):1064-71. doi: 10.1016/j.exphem.2011.08.006. Epub 2011 Aug 22.

PMID:
21864486
37.

Structural modifications of ionic liquid surfactants for improving the water dispersibility of carbon nanotubes: an experimental and theoretical study.

Di Crescenzo A, Aschi M, Del Canto E, Giordani S, Demurtas D, Fontana A.

Phys Chem Chem Phys. 2011 Jun 21;13(23):11373-83. doi: 10.1039/c1cp20140a. Epub 2011 May 16.

PMID:
21584329
38.

The reconstitution of the thymus in immunosuppressed individuals restores CD4-specific cellular and humoral immune responses.

Plana M, Garcia F, Darwich L, Romeu J, López A, Cabrera C, Massanella M, Canto E, Ruiz-Hernandez R, Blanco J, Sánchez M, Gatell JM, Clotet B, Ruiz L, Bofill M; Red de Investigación en Sida (RIS).

Immunology. 2011 Jul;133(3):318-28. doi: 10.1111/j.1365-2567.2011.03442.x. Epub 2011 Apr 19.

39.

Comparative transcriptome analysis of yeast strains carrying slt2, rlm1, and pop2 deletions.

Becerra M, Lombardía LJ, Lamas-Maceiras M, Canto E, Rodríguez-Belmonte E, Cerdán ME.

Genome. 2011 Feb;54(2):99-109. doi: 10.1139/G10-101.

PMID:
21326366
40.

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.

Comabella M, Fernández M, Martin R, Rivera-Vallvé S, Borrás E, Chiva C, Julià E, Rovira A, Cantó E, Alvarez-Cermeño JC, Villar LM, Tintoré M, Montalban X.

Brain. 2010 Apr;133(Pt 4):1082-93. doi: 10.1093/brain/awq035. Epub 2010 Mar 17.

PMID:
20237129
41.

MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.

Cantó E, Moga E, Ricart E, Garcia-Bosch O, Garcia-Planella E, Juarez C, Vidal S.

Inflamm Bowel Dis. 2009 Nov;15(11):1686-96. doi: 10.1002/ibd.21013.

PMID:
19572373
42.

NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.

Moga E, Alvarez E, Cantó E, Vidal S, Rodríguez-Sánchez JL, Sierra J, Briones J.

Exp Hematol. 2008 Jan;36(1):69-77. Epub 2007 Oct 23.

PMID:
17959301
43.

Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype.

Cantó E, Ricart E, Busquets D, Monfort D, García-Planella E, González D, Balanzó J, Rodriguez-Sanchez JL, Vidal S.

World J Gastroenterol. 2007 Nov 7;13(41):5446-53.

44.

An approach to the hypoxic and oxidative stress responses in Kluyveromyces lactis by analysis of mRNA levels.

Blanco M, Núñez L, Tarrío N, Canto E, Becerra M, González-Siso MI, Cerdán ME.

FEMS Yeast Res. 2007 Aug;7(5):702-14. Epub 2007 Apr 10.

45.

BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia.

Slawin KM, Shariat S, Canto E.

Rev Urol. 2005;7 Suppl 8:S52-6.

46.

Sural Nerve Interposition Grafting during Radical Prostatectomy.

Slawin KM, Canto EI, Shariat SF, Gore JL, Kim E, Kattan MW, Wheeler TM, Nath RK.

Rev Urol. 2002 Winter;4(1):17-23.

47.
48.

Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.

Paz Morante M, Briones J, Canto E, Sabzevari H, Martino R, Sierra J, Rodriguez-Sanchez JL, Vidal S.

Clin Exp Immunol. 2006 Jul;145(1):36-43.

49.

TNF alpha production to TLR2 ligands in active IBD patients.

Cantó E, Ricart E, Monfort D, González-Juan D, Balanzó J, Rodríguez-Sánchez JL, Vidal S.

Clin Immunol. 2006 May;119(2):156-65. Epub 2006 Feb 15.

PMID:
16480927
50.

Naive CD4+ cells from cord blood can generate competent Th effector cells.

Cantó E, Rodríguez-Sánchez JL, Vidal S.

Transplantation. 2005 Sep 27;80(6):850-8.

PMID:
16210975

Supplemental Content

Support Center